GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rayence Co Ltd (XKRX:228850) » Definitions » 5-Year EBITDA Growth Rate

Rayence Co (XKRX:228850) 5-Year EBITDA Growth Rate : 5.00% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Rayence Co 5-Year EBITDA Growth Rate?

Rayence Co's EBITDA per Share for the three months ended in Sep. 2024 was ₩227.76.

During the past 12 months, Rayence Co's average EBITDA Per Share Growth Rate was -26.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 60.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Rayence Co was 60.80% per year. The lowest was -31.00% per year. And the median was 2.30% per year.


Competitive Comparison of Rayence Co's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Rayence Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rayence Co's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rayence Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Rayence Co's 5-Year EBITDA Growth Rate falls into.



Rayence Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Rayence Co  (XKRX:228850) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Rayence Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Rayence Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Rayence Co Business Description

Traded in Other Exchanges
N/A
Address
14 Samsung 1-ro 1-gil, Gyeonggi-do, Hwaseong, KOR, 18449
Rayence Co Ltd is engaged in providing dental, medical, veterinary, and industrial X-ray detector products. It also has the techniques for designing products such as CMOS Wafer, developing flat panel detectors (TFT), and using the core technology of scintillator, which is used for radiation detection. TFT based detectors have diagnostic imaging capabilities with a high grey scale range. CMOS products provide both static and dynamic imaging capabilities and are produced utilizing ASIC design.

Rayence Co Headlines

No Headlines